Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2018

Open Access 01-12-2018 | Case report

Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report

Authors: Voahangy Andrianaivoarimanana, Eric Bertherat, Rojo Rajaonarison, Tiana Rakotondramaro, Christophe Rogier, Minoarisoa Rajerison

Published in: BMC Pulmonary Medicine | Issue 1/2018

Login to get access

Abstract

Background

Plague is a life-threatening disease caused by the bacterium, Yersinia pestis. Madagascar is the leading country for human plague cases worldwide. Human plague is a serious disease, particularly in its septicaemic and pneumonic forms. We report a case of pneumonic plague co-infected by a MDR-Stenotrophomonas maltophilia.

Case presentation

A 24 year-old man originated from Soavinandriana, a plague focus, felt uneasy and developed high fever with chills. He started treatment by himself, by private medical care and by a traditional healer for nine days moving several times from place to place. His condition had deteriorated when he presented to a district hospital with a syndrome of dyspnea, bronchial rale and altered state of consciousness. Two days later, plague diagnosis, performed as a last resort, revealed a positive F1 antigen on rapid diagnostic test. Additional tests (pla PCR and plague serology) evidenced a Y. pestis infection. However, streptomycin treatment did not achieve a complete recovery as the course of disease was complicated by the presence of MDR-S. maltophilia in his lung. This opportunistic infection could have been favored by an immunosuppression due to Y. pestis pulmonary infection and probably been acquired during his stay at a District Hospital. He was treated with a combination of ciprofloxacin and gentamycin and recovered fully.

Conclusions

Pneumonic plague infection may promote another virulent or avirulent bacterial infection particularly when it is not initially suspected. However, coinfection is rarely described and its occurrence frequency is unknown. In middle or low resources areas, which is the case of most plague endemic countries, control and prevention of infections in health facilities is not optimal. Co-infection with an opportunistic pathogen agent, such as S. maltophilia, is a risk which must not be disregarded as demonstrated by this case report. When deciding of a national control strategy, it should be taken into account in the choice of the first line treatment.
Literature
2.
go back to reference Price PA, Jin J, Goldman WE. Pulmonary infection by Yersinia pestis rapidly establishes a permissive environment for microbial proliferation. Proc Natl Acad Sci U S A. 2012;109:3083–8.CrossRefPubMedPubMedCentral Price PA, Jin J, Goldman WE. Pulmonary infection by Yersinia pestis rapidly establishes a permissive environment for microbial proliferation. Proc Natl Acad Sci U S A. 2012;109:3083–8.CrossRefPubMedPubMedCentral
3.
go back to reference World Health Organization. Plague around the world, 2010–2015. Wkly Epidemiol Rec. 2016;91:89–93. World Health Organization. Plague around the world, 2010–2015. Wkly Epidemiol Rec. 2016;91:89–93.
4.
go back to reference Brygoo ER. Epidemiologie de la peste à Madagascar. Arch Inst Pasteur Madagascar. 1966;35:9–147. Brygoo ER. Epidemiologie de la peste à Madagascar. Arch Inst Pasteur Madagascar. 1966;35:9–147.
5.
go back to reference World Health Organization. International meeting on preventing and controlling plague: the old calamity still has a future. Wkly Epidemiol Rec. 2006;81:278–84. World Health Organization. International meeting on preventing and controlling plague: the old calamity still has a future. Wkly Epidemiol Rec. 2006;81:278–84.
6.
go back to reference Galimand M, Guiyoule A, Gerbaud G, Rasoamanana B, Chanteau S, Carniel E, et al. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med. 1997;337:677–80.CrossRefPubMed Galimand M, Guiyoule A, Gerbaud G, Rasoamanana B, Chanteau S, Carniel E, et al. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med. 1997;337:677–80.CrossRefPubMed
7.
go back to reference Khardori N, Elting L, Wong E, Schable B, Bodey GP. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis. 1990;12:997–1003.CrossRefPubMed Khardori N, Elting L, Wong E, Schable B, Bodey GP. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis. 1990;12:997–1003.CrossRefPubMed
8.
go back to reference Looney WJ, Narita M, Mühlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis. 2009;9:312–23.CrossRefPubMed Looney WJ, Narita M, Mühlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis. 2009;9:312–23.CrossRefPubMed
9.
go back to reference Sendrasoa FA, Razanakoto NH, Ranaivo IM, Andrianasolo RL, Randria MJDD, Antibiotic RRA. Antimalarial Selfmedication in Antananarivo, Madagascar. Int J Infect Dis Ther. 2016;1:1–5. Sendrasoa FA, Razanakoto NH, Ranaivo IM, Andrianasolo RL, Randria MJDD, Antibiotic RRA. Antimalarial Selfmedication in Antananarivo, Madagascar. Int J Infect Dis Ther. 2016;1:1–5.
10.
go back to reference Chanteau S, Rahalison L, Ralafiarisoa L, Foulon J, Ratsitorahina M, Ratsifasoamanana L, et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet. 2003;361:211–6.CrossRefPubMed Chanteau S, Rahalison L, Ralafiarisoa L, Foulon J, Ratsitorahina M, Ratsifasoamanana L, et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet. 2003;361:211–6.CrossRefPubMed
11.
go back to reference Rasoamanana B, Rahalison L, Raharimanana C, Chanteau S. Comparison of Yersinia CIN agar and mouse inoculation assay for the diagnosis of plague. Trans R Soc Trop Med Hyg. 1996;90:651.CrossRefPubMed Rasoamanana B, Rahalison L, Raharimanana C, Chanteau S. Comparison of Yersinia CIN agar and mouse inoculation assay for the diagnosis of plague. Trans R Soc Trop Med Hyg. 1996;90:651.CrossRefPubMed
12.
go back to reference Rasoamanana B, Leroy F, Boisier P, Rasolomaharo M, Buchy P, Carniel E, et al. Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar. Clin Diagn Lab Immunol. 1997;4:587–91.PubMedPubMedCentral Rasoamanana B, Leroy F, Boisier P, Rasolomaharo M, Buchy P, Carniel E, et al. Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar. Clin Diagn Lab Immunol. 1997;4:587–91.PubMedPubMedCentral
13.
go back to reference Hinnebusch J, Schwan TG. New method for plague surveillance using polymerase chain reaction to detect Yersinia pestis in fleas. J Clin Microbiol. 1993;31:1511–4.PubMedPubMedCentral Hinnebusch J, Schwan TG. New method for plague surveillance using polymerase chain reaction to detect Yersinia pestis in fleas. J Clin Microbiol. 1993;31:1511–4.PubMedPubMedCentral
14.
go back to reference Pechous RD, Sivaraman V, Stasulli NM, Goldman WE. Pneumonic plague: the darker side of Yersinia pestis. Trends Microbiol. 2016;24:190–7.CrossRefPubMed Pechous RD, Sivaraman V, Stasulli NM, Goldman WE. Pneumonic plague: the darker side of Yersinia pestis. Trends Microbiol. 2016;24:190–7.CrossRefPubMed
15.
go back to reference Butler TC. Plague and other Yersinia infections. In: Greenough WB, editor. Current topics in infectious disease. New York: Plenum Medical Book Company; 1983. Butler TC. Plague and other Yersinia infections. In: Greenough WB, editor. Current topics in infectious disease. New York: Plenum Medical Book Company; 1983.
17.
go back to reference Bertherat E, Thullier P, Shako JC, England K, Koné ML, Arntzen L, et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerg Infect Dis. 2011;17:778–84.CrossRefPubMedPubMedCentral Bertherat E, Thullier P, Shako JC, England K, Koné ML, Arntzen L, et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerg Infect Dis. 2011;17:778–84.CrossRefPubMedPubMedCentral
18.
19.
go back to reference Ratsitorahina M, Chanteau S, Rahalison L, Ratsifasoamanana L, Boisier P. Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet. 2000;355:111–3.CrossRefPubMed Ratsitorahina M, Chanteau S, Rahalison L, Ratsifasoamanana L, Boisier P. Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet. 2000;355:111–3.CrossRefPubMed
20.
go back to reference Nicodemo AC, Garcia Paez JI. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis. 2007;26:229–37.CrossRefPubMed Nicodemo AC, Garcia Paez JI. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis. 2007;26:229–37.CrossRefPubMed
21.
go back to reference Fujita J, Yamadori I, Xu G, et al. Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients. Respir Med. 1996;90:35–8.CrossRefPubMed Fujita J, Yamadori I, Xu G, et al. Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients. Respir Med. 1996;90:35–8.CrossRefPubMed
22.
go back to reference Pathmanathan A, Waterer GW. Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection. EurRespir J. 2005;25:911–4.CrossRef Pathmanathan A, Waterer GW. Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection. EurRespir J. 2005;25:911–4.CrossRef
23.
go back to reference Samonis G, Karageorgopoulos DE, Maraki S, Levis P, Dimopoulou D, Spernovasilis NA, et al. Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One. 2012;7:e37375.CrossRefPubMedPubMedCentral Samonis G, Karageorgopoulos DE, Maraki S, Levis P, Dimopoulou D, Spernovasilis NA, et al. Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One. 2012;7:e37375.CrossRefPubMedPubMedCentral
24.
go back to reference Apangu T, Griffith K, Abaru J, Candini G, Apio H, Okoth F, et al. Successful treatment of human plague with oral ciprofloxacin. Emerg Infect Dis. 2017;23(3):553–55. Apangu T, Griffith K, Abaru J, Candini G, Apio H, Okoth F, et al. Successful treatment of human plague with oral ciprofloxacin. Emerg Infect Dis. 2017;23(3):553–55.
25.
go back to reference Heine HS, Hershfield J, Marchand C, Miller L, Halasohoris S, Purcell BK, et al. In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods. Antimicrob Agents Chemother. 2015;59:1919–21.CrossRefPubMedPubMedCentral Heine HS, Hershfield J, Marchand C, Miller L, Halasohoris S, Purcell BK, et al. In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods. Antimicrob Agents Chemother. 2015;59:1919–21.CrossRefPubMedPubMedCentral
26.
go back to reference Wong JD, Barash JR, Sandfort RF, Janda JM. Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents. Antimicrob Agents Chemother. 2000;44:1995–6.CrossRefPubMedPubMedCentral Wong JD, Barash JR, Sandfort RF, Janda JM. Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents. Antimicrob Agents Chemother. 2000;44:1995–6.CrossRefPubMedPubMedCentral
28.
go back to reference Quan TJ, Tsuchiya KR, Carter LG. Isolation of pathogens other than Yersinia pestis during plague investigations. J Wildl Dis. 1979;15:505–10.CrossRefPubMed Quan TJ, Tsuchiya KR, Carter LG. Isolation of pathogens other than Yersinia pestis during plague investigations. J Wildl Dis. 1979;15:505–10.CrossRefPubMed
29.
go back to reference Bertherat E, Mueller MJ, Shako JC, Picardeau M. Discovery of a leptospirosis cluster amidst a pneumonic plague outbreak in a miners’ camp in the Democratic Republic of the Congo. Int J Environ Res Public Health. 2014;11:1824–33.CrossRefPubMedPubMedCentral Bertherat E, Mueller MJ, Shako JC, Picardeau M. Discovery of a leptospirosis cluster amidst a pneumonic plague outbreak in a miners’ camp in the Democratic Republic of the Congo. Int J Environ Res Public Health. 2014;11:1824–33.CrossRefPubMedPubMedCentral
Metadata
Title
Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report
Authors
Voahangy Andrianaivoarimanana
Eric Bertherat
Rojo Rajaonarison
Tiana Rakotondramaro
Christophe Rogier
Minoarisoa Rajerison
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2018
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-018-0656-y

Other articles of this Issue 1/2018

BMC Pulmonary Medicine 1/2018 Go to the issue